Key result
Ebstein anomaly reconstructive surgery yields ~97% 25-year survival, with Cone repair linked to less TR progression.
Why the study?
To describe the characteristics and long-term outcomes of a single-centre cohort undergoing vertical plication repair with detachment and reattachment of the tricuspid valve for Ebstein anomaly.
Does reconstructive surgery for Ebstein anomaly provide durable long-term survival and valve function?
Cohort (n=36)
No
Does reconstructive surgery for Ebstein anomaly provide durable long-term survival and valve function?
Reconstructive surgery for Ebstein anomaly demonstrates excellent long-term survival and freedom from reoperation up to 25 years, particularly with the Cone repair technique.
Supports reconstructive surgery for durable Ebstein outcomes; leaves open generalizability and need for controlled comparisons of Cone repair.
OBJECTIVES: Since 1988, our centre employs vertical plication repair with deattachment and reattachment of the tricuspid valve for Ebstein anomaly. This study describes the characteristics and long-term outcomes of our single-centre cohort. METHODS: Data from all patients operated on between 1988 and 2016 were retrospectively collected. Kaplan-Meier analyses were done for survival data and mixed models were used to analyse longitudinally collected clinical and echocardiography data. RESULTS: Thirty-six patients (mean age: 25.4 ± 15.9 years, 36% male) were operated on using the Carpentier-Chauvaud 21 (58%) or Cone repair 15 (42%). One patient (3%) died in hospital. Two late deaths were observed, yielding a survival of 97 ± 3% at 25 years. Reoperation was performed in 6 patients after a mean follow-up of 14.1 ± 10.3 years, resulting in a freedom of reoperation of 80 ± 8% at 25 years. During follow-up, predicted probability of being in New York Heart Association III/IV did not exceed 10%. Modelling longitudinal evolution of tricuspid regurgitation showed no major changes over time. Additionally, a rigid ring repair was associated with a higher probability of tricuspid regurgitation, especially after the first years after the operation. A full Cone repair was associated with less progression of tricuspid regurgitation over time. CONCLUSIONS: Repair of Ebstein abnomaly is associated with low mortality and morbidity, acceptable reoperation rate and excellent valve function over time, especially in patients with completed Cone repair. Therefore, we conclude that in our centre, repair of Ebstein abnomaly is a durable technique to treat patients.
No takes yet. Share an insight, caveat, or question.
Veen et al. (2019) conducted a cohort in Ebstein anomaly (n=36). Reconstructive surgery (Carpentier-Chauvaud or Cone repair) was evaluated on Survival at 25 years. Reconstructive surgery for Ebstein anomaly yielded a 25-year survival of 97 ± 3% and freedom from reoperation of 80 ± 8%, with Cone repair associated with less progression of tricuspid regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: